Investors NYSE AMERICAN: LCTX Minimum 15 minutes delayed. Source: LSEG VIEW STOCK QUOTE Press Releases March 24, 2026 Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease March 05, 2026 Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update February 26, 2026 Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics Corporate Overview (March 24, 2026) 4.9 MB Roche Pharma Day 2025 Presentation 8.1 MB OpRegen® 3 Year Clinical Data Update (Clinical Trials at the Summit 2025) 945.1 KB Fourth Quarter and Full Year 2025 Financial Results Earnings Call Mar 5, 2026 at 4:30 PM EST Click here for webcast VIEW EVENTS & PRESENTATIONS
March 05, 2026 Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 26, 2026 Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026
Fourth Quarter and Full Year 2025 Financial Results Earnings Call Mar 5, 2026 at 4:30 PM EST Click here for webcast
